Influenza Medication Market size accounted for US$ 895 Mn in 2021 and is anticipated to expand at a CAGR of 2.1% By 2032 | insightSLICE
The global Influenza Medication market size was estimated to be US$ 895 million in 2021 and is expected grow at a CAGR of 2.1% between 2023 to 2032.
In the report “Influenza Medication Market,” industry trends, research, and predictions for the years 2022–2032 are presented. Here 2020 represents the historical period, 2021 is the baseline period, and the projected period runs from 2022 through 2032.
Access the sample report: https://www.insightslice.com/request-sample/355
The research takes into account the competitive environment, and the report will give an overview of the major companies in the global market for influenza medications as well as their market forecasts.
In addition, the report will include information on important advancements, global and regional sales networks, business strategies, research and development initiatives, staff strength, and key executives for all significant market participants.
The key players of the Global Influenza Medication Market are:
Genentech, Inc., GlaxoSmithKline plc, Amneal Pharmaceuticals LLC, Alvogen, Daiichi Sankyo Company, F. Hoffmann-La Roche Ltd., BIOCRYST PHARMACEUTICALS, INC., Lupin Limited, Teva Pharmaceutical Industries Ltd., Mylan, Inc., Natco Pharma, Novartis AG, Sun Pharmaceutical Industries Ltd., and Zydus Pharmaceuticals, Inc. are significant market participants in the global influenza medication market.
Driving factors for the growth of Global Influenza Medication Market
Due to the seasonal nature of influenza, healthcare organizations and pharmaceutical companies are concentrating on the creation of cutting-edge drugs and raising public understanding of the illness. Type-A and type-B influenza viruses are thought to be in charge of epidemic and global outbreaks, respectively.
Fever, muscle aches, weariness, severe cold, coughing, and sore throat are among the symptoms of influenza, which can also result in chronic respiratory conditions. Pregnant women, elderly persons, and people with a history of illness are particularly vulnerable to influenza viruses.
Read more about the report inclusions: https://www.insightslice.com/influenza-medication-market
The Rapid Influenza Diagnostic Test (RIDT) is a type-A and type-B seasonal influenza testing method based on an antigen detection assay. RIDTs are broadly applied and are developing quickly as technology advances.
The industry’s leading competitors are concentrating on the creation of novel therapy for the treatment of flu, which would be projected to support the growth of the global market for influenza medications during the forecast timeframe.
Regional performance of Influenza Medication Market
In 2019, North America accounted for a lion’s share of the global market for anti-influenza drugs, and it is projected to rise significantly over the next years.
The key drivers of the North American influenza medication industry include the rise in influenza tests, the incidence of the disease, rising investments in novel drug discovery, government campaigns to encourage influenza vaccines, and benevolent insurance reimbursement practices.
Due to the high frequency of influenza in China, India, and Southeast Asian nations, Asia Pacific is expected to have considerable growth throughout the forecast period.
Additionally, the pharmaceutical companies in the area are collaborating closely with the healthcare authorities to increase flu awareness while also expanding their manufacturing capacities to meet the growing demand. In the upcoming years, this is anticipated to augment the growth of the Asia Pacific influenza medicine market.
Global Influenza Medication Market Key Segments:
By Product
- Zanamivir
- Oseltamivir
- Peramivir
- Amantadine
- Rimantadine
- Inosine
- Others
By Distribution Channel
- Hospitals
- Clinics
- Pharmacies
- Others
By Geography:
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Rest of South America
Related reports:
Global Influenza Medication Market: https://www.insightslice.com/influenza-medication-market
Global Drug Delivery Devices Market: https://www.insightslice.com/drug-delivery-devices-market
Data coverage of our report:
With an emphasis on major companies present in the Influenza Medication Market, this report offers an in-depth analysis of leading companies with a majority share of the global market.
This would help you to identify the company segment focused on influenza drugs and vaccinations. It will also estimate the market shares of well-known firms in the global market for influenza medications.
The study takes also into account essential competitive data from all manufacturers of influenza medications, including company strategy, product portfolio, key developments, SWOT analysis, and research and development priorities.
The actors involved in the market’s supply chain and value chain, as well as their contributions, will be taken into account in the analysis of the global market for influenza medications. All of the goods in the company’s influenza medication business segment would be the main focus of the product portfolio.
Similar to this, the section on recent developments would concentrate on the company’s most recent activities, such as strategic alliances and partnerships, mergers and acquisitions, the introduction of new products, and geographic expansion in the market for anti-influenza drugs.
Proceed to purchase: https://www.insightslice.com/buy-now/355
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at info@insightslice.com.
Contact us:
Alex R
+1 707 736 6633
Editor Details
-
Company:
- insightSLICE
- Website:
